X Par 100 mg/2.5 mg Tablet
By X Par
Rx
10 Tablet in a Strip

Composition
Guaifenesin(100mg) + Terbutaline(2.5mg)

Manufacturer - Bombay Tablet Mfg Co Pvt Ltd
Bombay Tablet Mfg. Co. Pvt. Ltd., Off. 304, S. Gandhi Marg, Mumbai - 400 002.

Expires on or after
October, 2025

liver
When it comes to using X Par 100 mg/2.5 mg Tablet, one must be cautious if they have liver disease. It is advisable to seek guidance from a healthcare provider as dose adjustment of the medication may be necessary for individuals with liver issues. The information available regarding the use of X Par 100 mg/2.5 mg Tablet in patients with liver disease is limited, emphasizing the importance of consulting a doctor before starting or continuing the medication.

kidney
X Par 100 mg/2.5 mg Tablet requires caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor.

alcohol
Consult your doctor when consuming alcohol with X Par 100 mg/2.5 mg Tablet.

driving
X Par 100 mg/2.5 mg Tablet does not typically impact driving abilities.

pregnancy
X Par 100 mg/2.5 mg Tablet is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Kindly consult your doctor for guidance.

breastfeeding
X Par 100 mg/2.5 mg Tablet is likely safe for breastfeeding as per limited human data, indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹19
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025